Sphingosine kinase mediates resistance to the synthetic retinoid N-(4-hydroxyphenyl)retinamide in human ovarian cancer cells.
about
Sphingosine kinase 1 in cancer.Evaluation of bioactive sphingolipids in 4-HPR-resistant leukemia cellsThe sphingosine kinase 1 inhibitor 2-(p-hydroxyanilino)-4-(p-chlorophenyl)thiazole induces proteasomal degradation of sphingosine kinase 1 in mammalian cellsApoptotic sphingolipid ceramide in cancer therapy.A glycosphingolipid/caveolin-1 signaling complex inhibits motility of human ovarian carcinoma cells.Sphingosine kinase 1 as an anticancer therapeutic target.Soy Protein Isolate Protects Against Ethanol-Mediated Tumor Progression in Diethylnitrosamine-Treated Male MiceAberrant lipid metabolism: an emerging diagnostic and therapeutic target in ovarian cancer.Sphingosine 1-phosphate: a potential molecular target for ovarian cancer therapy?Sphingosine kinase 1 as a potential therapeutic target in epithelial ovarian cancer.Fenretinide sensitizes multidrug-resistant human neuroblastoma cells to antibody-independent and ch14.18-mediated NK cell cytotoxicity.Sphingosine-1-phosphate receptor-3 signaling up-regulates epidermal growth factor receptor and enhances epidermal growth factor receptor-mediated carcinogenic activities in cultured lung adenocarcinoma cells.Inhibition of acid ceramidase by a 2-substituted aminoethanol amide synergistically sensitizes prostate cancer cells to N-(4-hydroxyphenyl) retinamide.NMR metabolomics highlights sphingosine kinase-1 as a new molecular switch in the orchestration of aberrant metabolic phenotype in cancer cells.Inhibition of dihydroceramide desaturase activity by the sphingosine kinase inhibitor SKI II.Selectivity and specificity of sphingosine-1-phosphate receptor ligands: caveats and critical thinking in characterizing receptor-mediated effects.
P2860
Q33853998-33738E56-6E75-4A9A-8745-25D7AB0E8853Q34068899-6A9C345A-D310-4241-819B-EABC13F1190FQ34385814-A499AA13-1450-477E-91C3-921BA67F91C2Q34736760-407BC479-54DD-4597-9125-7CFDB78EA165Q35562449-3A5DD4EC-A7D2-4685-9964-1E2BDE9E8414Q35794452-13857990-FB2A-4A1E-BC1B-34F6F859675DQ35967096-59A1541F-BA84-45F9-B4A3-303980620627Q36820509-83970F2E-D002-4AC6-9898-57D93A958E29Q38185438-4EB57DC5-0A55-4D73-8FDC-2AC720F7F8E7Q38937332-31FB9E44-0B3A-4F28-867D-31312C4F3FACQ39262615-DBC81E6E-ED34-426C-9164-0CF1F1FE502EQ39394808-DBCB9902-CF53-4E40-9345-8AA48AABC13AQ39545354-E27E73FB-3C4C-4443-8585-853D2E0DE442Q41127962-F0849787-E511-4267-90D2-38A259AFE0B1Q41828412-B920F9CE-2F3A-4CD8-8AE1-09874A4420D1Q42127017-46803272-A556-409E-949D-2E09C1EFC2C1
P2860
Sphingosine kinase mediates resistance to the synthetic retinoid N-(4-hydroxyphenyl)retinamide in human ovarian cancer cells.
description
2010 nî lūn-bûn
@nan
2010 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
Sphingosine kinase mediates re ...... in human ovarian cancer cells.
@ast
Sphingosine kinase mediates re ...... in human ovarian cancer cells.
@en
type
label
Sphingosine kinase mediates re ...... in human ovarian cancer cells.
@ast
Sphingosine kinase mediates re ...... in human ovarian cancer cells.
@en
prefLabel
Sphingosine kinase mediates re ...... in human ovarian cancer cells.
@ast
Sphingosine kinase mediates re ...... in human ovarian cancer cells.
@en
P2093
P2860
P50
P356
P1476
Sphingosine kinase mediates re ...... in human ovarian cancer cells
@en
P2093
Chiara Donati
Gianluca Frera
Giuditta Illuzzi
Manuela Valsecchi
Simona Prioni
Vanna Chigorno
P2860
P304
18594-18602
P356
10.1074/JBC.M109.072801
P407
P577
2010-04-19T00:00:00Z